Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Derek Archila's Stock Ratings
Wells Fargo Analyst
Derek Archila is an analyst at Wells Fargo. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
16.7%
Smart Score
Overall Average Return Percentile
71st
Number of Ratings
264
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/11/2025 | ARGX | Buy Now | argenx | $851.52 | 54.55% | $1095 → $1316 | Maintains | Overweight | Get Alert | |
| 12/09/2025 | KYMR | Buy Now | Kymera Therapeutics | $89.04 | 30.28% | $69 → $116 | Maintains | Overweight | Get Alert | |
| 12/08/2025 | ORIC | Buy Now | ORIC Pharmaceuticals | $9.67 | 158.66% | $19 → $25 | Maintains | Overweight | Get Alert | |
| 12/08/2025 | INCY | Buy Now | Incyte | $97.12 | 19.44% | $97 → $116 | Maintains | Overweight | Get Alert | |
| 11/19/2025 | ANNX | Buy Now | Annexon | $4.99 | 441.08% | $14 → $27 | Maintains | Overweight | Get Alert | |
| 11/14/2025 | ORIC | Buy Now | ORIC Pharmaceuticals | $9.67 | 96.58% | $20 → $19 | Maintains | Overweight | Get Alert | |
| 11/14/2025 | SEPN | Buy Now | Septerna | $27.71 | 1.05% | $18 → $28 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 11/11/2025 | BBIO | Buy Now | BridgeBio Pharma | $75.20 | 11.7% | $76 → $84 | Maintains | Overweight | Get Alert | |
| 11/11/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $398.33 | 20.25% | $395 → $479 | Maintains | Equal-Weight | Get Alert | |
| 11/07/2025 | VTYX | Buy Now | Ventyx Biosciences | $8.13 | 72.2% | $11 → $14 | Maintains | Overweight | Get Alert | |
| 11/07/2025 | GLUE | Buy Now | Monte Rosa Therapeutics | $16.00 | -18.75% | $10 → $13 | Maintains | Equal-Weight | Get Alert | |
| 11/06/2025 | ARVN | Buy Now | Arvinas | $12.62 | 18.86% | $16 → $15 | Maintains | Overweight | Get Alert | |
| 11/05/2025 | SLNO | Buy Now | Soleno Therapeutics | $51.29 | 106.67% | $123 → $106 | Maintains | Overweight | Get Alert | |
| 11/05/2025 | KYMR | Buy Now | Kymera Therapeutics | $89.04 | -22.51% | $53 → $69 | Maintains | Overweight | Get Alert | |
| 11/05/2025 | ANAB | Buy Now | AnaptysBio | $45.50 | 78.02% | $51 → $81 | Maintains | Overweight | Get Alert | |
| 10/30/2025 | KYTX | Buy Now | Kyverna Therapeutics | $10.95 | 183.19% | $27 → $31 | Maintains | Overweight | Get Alert | |
| 10/29/2025 | INCY | Buy Now | Incyte | $97.12 | -0.12% | $89 → $97 | Maintains | Overweight | Get Alert | |
| 10/23/2025 | NRIX | Buy Now | Nurix Therapeutics | $19.06 | 10.18% | $22 → $21 | Maintains | Overweight | Get Alert | |
| 10/21/2025 | EXEL | Buy Now | Exelixis | $41.62 | -27.92% | $36 → $30 | Maintains | Equal-Weight | Get Alert | |
| 10/17/2025 | KZR | Buy Now | Kezar Life Sciences | $6.28 | -20.38% | $7 → $5 | Maintains | Equal-Weight | Get Alert | |
| 10/15/2025 | APLS | Buy Now | Apellis Pharmaceuticals | $25.22 | 26.88% | $29 → $32 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 10/08/2025 | KYTX | Buy Now | Kyverna Therapeutics | $10.95 | 146.65% | $24 → $27 | Maintains | Overweight | Get Alert | |
| 09/23/2025 | CCCC | Buy Now | C4 Therapeutics | $2.48 | 304.04% | $5 → $10 | Maintains | Overweight | Get Alert | |
| 09/16/2025 | ATYR | Buy Now | aTyr Pharma | $0.75 | 32.74% | $25 → $1 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 08/20/2025 | CLDX | Buy Now | Celldex Therapeutics | $27.88 | 36.3% | $44 → $38 | Maintains | Overweight | Get Alert | |
| 08/20/2025 | SLNO | Buy Now | Soleno Therapeutics | $51.29 | 139.81% | → $123 | Initiates | → Overweight | Get Alert | |
| 08/12/2025 | STRO | Buy Now | Sutro Biopharma | $9.76 | -69.26% | $4 → $3 | Maintains | Equal-Weight | Get Alert | |
| 08/08/2025 | CABA | Buy Now | Cabaletta Bio | $2.41 | -17.01% | $3 → $2 | Maintains | Equal-Weight | Get Alert | |
| 08/08/2025 | ASND | Buy Now | Ascendis Pharma | $220.00 | 34.09% | $289 → $295 | Maintains | Overweight | Get Alert | |
| 08/07/2025 | ZNTL | Buy Now | Zentalis Pharma | $1.38 | 262.32% | $6 → $5 | Maintains | Equal-Weight | Get Alert | |
| 08/07/2025 | VRDN | Buy Now | Viridian Therapeutics | $33.40 | -22.16% | $27 → $26 | Maintains | Equal-Weight | Get Alert | |
| 08/07/2025 | ARVN | Buy Now | Arvinas | $12.62 | 26.78% | $19 → $16 | Maintains | Overweight | Get Alert | |
| 08/06/2025 | INCY | Buy Now | Incyte | $97.12 | -8.36% | $67 → $89 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 07/31/2025 | ARGX | Buy Now | argenx | $851.52 | -11.22% | $741 → $756 | Maintains | Overweight | Get Alert | |
| 07/30/2025 | INCY | Buy Now | Incyte | $97.12 | -31.01% | $59 → $67 | Maintains | Equal-Weight | Get Alert | |
| 07/25/2025 | ALMS | Buy Now | Alumis | $11.45 | 48.47% | → $17 | Initiates | → Overweight | Get Alert | |
| 07/10/2025 | RYTM | Buy Now | Rhythm Pharmaceuticals | $113.79 | 13.37% | $91 → $129 | Maintains | Overweight | Get Alert | |
| 06/26/2025 | KYMR | Buy Now | Kymera Therapeutics | $89.04 | -40.48% | $57 → $53 | Maintains | Overweight | Get Alert | |
| 06/20/2025 | ATYR | Buy Now | aTyr Pharma | $0.75 | 3218.51% | $17 → $25 | Maintains | Overweight | Get Alert | |
| 06/17/2025 | BPMC | Buy Now | Blueprint Medicines | — | — | $143 → $129 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 06/02/2025 | APLS | Buy Now | Apellis Pharmaceuticals | $25.22 | 14.99% | $26 → $29 | Maintains | Equal-Weight | Get Alert | |
| 05/16/2025 | SEPN | Buy Now | Septerna | $27.71 | -35.04% | $11 → $18 | Maintains | Equal-Weight | Get Alert | |
| 05/08/2025 | APLS | Buy Now | Apellis Pharmaceuticals | $25.22 | 3.09% | $30 → $26 | Maintains | Equal-Weight | Get Alert | |
| 05/02/2025 | ARVN | Buy Now | Arvinas | $12.62 | 50.55% | $26 → $19 | Maintains | Overweight | Get Alert | |
| 04/30/2025 | INCY | Buy Now | Incyte | $97.12 | -39.25% | $58 → $59 | Maintains | Equal-Weight | Get Alert | |
| 04/09/2025 | NRIX | Buy Now | Nurix Therapeutics | $19.06 | 31.16% | $32 → $25 | Maintains | Overweight | Get Alert | |
| 04/07/2025 | RYTM | Buy Now | Rhythm Pharmaceuticals | $113.79 | -20.03% | $80 → $91 | Maintains | Overweight | Get Alert | |
| 04/01/2025 | CABA | Buy Now | Cabaletta Bio | $2.41 | 24.48% | $6 → $3 | Maintains | Equal-Weight | Get Alert | |
| 03/28/2025 | SEPN | Buy Now | Septerna | $27.71 | -60.3% | $14 → $11 | Maintains | Equal-Weight | Get Alert | |
| 03/21/2025 | GLUE | Buy Now | Monte Rosa Therapeutics | $16.00 | -37.5% | $11 → $10 | Maintains | Equal-Weight | Get Alert | |
| 03/12/2025 | ARVN | Buy Now | Arvinas | $12.62 | 106.02% | $60 → $26 | Maintains | Overweight | Get Alert | |
| 03/12/2025 | QTTB | Buy Now | Q32 Bio | $2.91 | 415.07% | $16 → $15 | Maintains | Equal-Weight | Get Alert | |
| 02/28/2025 | ARGX | Buy Now | argenx | $851.52 | -12.98% | $723 → $741 | Maintains | Overweight | Get Alert | |
| 02/24/2025 | EXEL | Buy Now | Exelixis | $41.62 | -13.5% | $36 → $36 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 02/18/2025 | SEPN | Buy Now | Septerna | $27.71 | -49.48% | $43 → $14 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 02/13/2025 | ANAB | Buy Now | AnaptysBio | $45.50 | 12.09% | $40 → $51 | Maintains | Overweight | Get Alert | |
| 01/30/2025 | ZNTL | Buy Now | Zentalis Pharma | $1.38 | 334.78% | $8 → $6 | Maintains | Equal-Weight | Get Alert | |
| 12/19/2024 | ARGX | Buy Now | argenx | $851.52 | -15.09% | $639 → $723 | Maintains | Overweight | Get Alert | |
| 12/19/2024 | ZYME | Buy Now | Zymeworks | $25.82 | -45.77% | $12 → $14 | Maintains | Equal-Weight | Get Alert | |
| 12/19/2024 | KZR | Buy Now | Kezar Life Sciences | $6.28 | 43.31% | $11 → $9 | Maintains | Equal-Weight | Get Alert | |
| 12/19/2024 | INCY | Buy Now | Incyte | $97.12 | -27.92% | $68 → $70 | Maintains | Equal-Weight | Get Alert | |
| 12/19/2024 | IMVT | Buy Now | Immunovant | $26.90 | 67.29% | $47 → $45 | Maintains | Overweight | Get Alert | |
| 12/19/2024 | CABA | Buy Now | Cabaletta Bio | $2.41 | 148.96% | $12 → $6 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 12/19/2024 | CCCC | Buy Now | C4 Therapeutics | $2.48 | 384.85% | $8 → $12 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 12/19/2024 | GLUE | Buy Now | Monte Rosa Therapeutics | $16.00 | -31.25% | $14 → $11 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 12/19/2024 | VRDN | Buy Now | Viridian Therapeutics | $33.40 | -19.16% | → $27 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 12/12/2024 | ANAB | Buy Now | AnaptysBio | $45.50 | -12.09% | $56 → $40 | Maintains | Overweight | Get Alert | |
| 12/11/2024 | SLRN | Buy Now | Acelyrin | — | — | $15 → $13 | Maintains | Overweight | Get Alert | |
| 12/11/2024 | QTTB | Buy Now | Q32 Bio | $2.91 | 449.41% | $95 → $16 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 12/02/2024 | KYMR | Buy Now | Kymera Therapeutics | $89.04 | -35.98% | $38 → $57 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 11/19/2024 | SEPN | Buy Now | Septerna | $27.71 | 55.18% | → $43 | Initiates | → Overweight | Get Alert | |
| 11/15/2024 | CABA | Buy Now | Cabaletta Bio | $2.41 | 397.93% | $20 → $12 | Maintains | Overweight | Get Alert | |
| 11/15/2024 | KYTX | Buy Now | Kyverna Therapeutics | $10.95 | 119.24% | $44 → $24 | Maintains | Overweight | Get Alert | |
| 11/14/2024 | KZR | Buy Now | Kezar Life Sciences | $6.28 | 75.16% | $20 → $11 | Maintains | Equal-Weight | Get Alert | |
| 11/06/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $25.22 | 18.95% | $43 → $30 | Maintains | Equal-Weight | Get Alert | |
| 11/01/2024 | ARGX | Buy Now | argenx | $851.52 | -24.96% | $547 → $639 | Maintains | Overweight | Get Alert | |
| 11/01/2024 | ZYME | Buy Now | Zymeworks | $25.82 | -53.52% | $12 → $12 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 10/31/2024 | BPMC | Buy Now | Blueprint Medicines | — | — | $153 → $151 | Maintains | Overweight | Get Alert | |
| 10/30/2024 | INCY | Buy Now | Incyte | $97.12 | -29.98% | $62 → $68 | Maintains | Equal-Weight | Get Alert | |
| 10/30/2024 | EXEL | Buy Now | Exelixis | $41.62 | -13.5% | $32 → $36 | Maintains | Overweight | Get Alert | |
| 10/16/2024 | SLRN | Buy Now | Acelyrin | — | — | $13 → $15 | Maintains | Overweight | Get Alert | |
| 10/10/2024 | INCY | Buy Now | Incyte | $97.12 | -36.16% | $63 → $62 | Maintains | Equal-Weight | Get Alert | |
| 10/04/2024 | ATYR | Buy Now | aTyr Pharma | $0.75 | 2156.59% | → $17 | Initiates | → Overweight | Get Alert | |
| 09/24/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $25.22 | 70.5% | $47 → $43 | Maintains | Equal-Weight | Get Alert | |
| 09/17/2024 | ASND | Buy Now | Ascendis Pharma | $220.00 | 31.36% | $264 → $289 | Maintains | Overweight | Get Alert | |
| 09/04/2024 | ASND | Buy Now | Ascendis Pharma | $220.00 | 20% | $277 → $264 | Maintains | Overweight | Get Alert | |
| 08/12/2024 | VTYX | Buy Now | Ventyx Biosciences | $8.13 | 35.3% | $16 → $11 | Maintains | Overweight | Get Alert | |
| 08/12/2024 | CLDX | Buy Now | Celldex Therapeutics | $27.88 | 32.71% | $35 → $37 | Maintains | Equal-Weight | Get Alert | |
| 08/12/2024 | KYMR | Buy Now | Kymera Therapeutics | $89.04 | -57.32% | $30 → $38 | Maintains | Equal-Weight | Get Alert | |
| 08/12/2024 | CABA | Buy Now | Cabaletta Bio | $2.41 | 729.88% | $35 → $20 | Maintains | Overweight | Get Alert | |
| 08/12/2024 | GLUE | Buy Now | Monte Rosa Therapeutics | $16.00 | 6.25% | $18 → $17 | Maintains | Overweight | Get Alert | |
| 07/26/2024 | ARGX | Buy Now | argenx | $851.52 | -35.76% | $543 → $547 | Maintains | Overweight | Get Alert | |
| 07/08/2024 | SLRN | Buy Now | Acelyrin | — | — | $13 → $13 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 06/24/2024 | ARGX | Buy Now | argenx | $851.52 | -36.35% | $478 → $542 | Maintains | Overweight | Get Alert | |
| 06/18/2024 | ZNTL | Buy Now | Zentalis Pharma | $1.38 | 552.17% | $29 → $9 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 05/23/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $25.22 | 90.33% | $57 → $48 | Maintains | Equal-Weight | Get Alert | |
| 05/15/2024 | ANNX | Buy Now | Annexon | $4.99 | 100.4% | $12 → $10 | Maintains | Overweight | Get Alert | |
| 05/09/2024 | CCCC | Buy Now | C4 Therapeutics | $2.48 | 223.23% | $7 → $8 | Maintains | Equal-Weight | Get Alert | |
| 05/09/2024 | ARVN | Buy Now | Arvinas | $12.62 | 375.44% | $63 → $60 | Maintains | Overweight | Get Alert | |
| 05/03/2024 | ZYME | Buy Now | Zymeworks | $25.82 | -53.52% | $14 → $12 | Maintains | Overweight | Get Alert | |
| 05/03/2024 | ASND | Buy Now | Ascendis Pharma | $220.00 | 19.09% | $260 → $262 | Maintains | Overweight | Get Alert | |
| 04/18/2024 | RYTM | Buy Now | Rhythm Pharmaceuticals | $113.79 | -54.3% | $53 → $52 | Maintains | Overweight | Get Alert | |
| 04/11/2024 | ANAB | Buy Now | AnaptysBio | $45.50 | 23.08% | → $56 | Initiates | → Overweight | Get Alert | |
| 04/01/2024 | ANNX | Buy Now | Annexon | $4.99 | 140.48% | $12 → $12 | Maintains | Overweight | Get Alert | |
| 03/27/2024 | ANNX | Buy Now | Annexon | $4.99 | 140.48% | $11 → $12 | Maintains | Overweight | Get Alert | |
| 03/22/2024 | CABA | Buy Now | Cabaletta Bio | $2.41 | 1352.28% | $34 → $35 | Maintains | Overweight | Get Alert | |
| 03/21/2024 | SLRN | Buy Now | Acelyrin | — | — | $11 → $13 | Maintains | Equal-Weight | Get Alert | |
| 03/15/2024 | ASND | Buy Now | Ascendis Pharma | $220.00 | 18.18% | $196 → $260 | Maintains | Overweight | Get Alert | |
| 03/14/2024 | MOR | Buy Now | MorphoSys | — | — | $17 → $18.25 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 03/12/2024 | ZYME | Buy Now | Zymeworks | $25.82 | -45.77% | $12 → $14 | Maintains | Overweight | Get Alert | |
| 03/12/2024 | VTYX | Buy Now | Ventyx Biosciences | $8.13 | 96.8% | $7 → $16 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 02/20/2024 | ARGX | Buy Now | argenx | $851.52 | -43.87% | $472 → $478 | Maintains | Overweight | Get Alert | |
| 02/16/2024 | NRIX | Buy Now | Nurix Therapeutics | $19.06 | 4.93% | $23 → $20 | Maintains | Overweight | Get Alert | |
| 02/05/2024 | MOR | Buy Now | MorphoSys | — | — | → $17 | Reiterates | Overweight → Overweight | Get Alert | |
| 12/21/2023 | ARGX | Buy Now | argenx | $851.52 | -44.8% | $585 → $470 | Maintains | Overweight | Get Alert | |
| 12/19/2023 | KYMR | Buy Now | Kymera Therapeutics | $89.04 | -70.8% | → $26 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 12/19/2023 | VTYX | Buy Now | Ventyx Biosciences | $8.13 | -63.1% | $8 → $3 | Maintains | Equal-Weight | Get Alert | |
| 12/19/2023 | RYTM | Buy Now | Rhythm Pharmaceuticals | $113.79 | -53.42% | $48 → $53 | Maintains | Overweight | Get Alert | |
| 12/19/2023 | BPMC | Buy Now | Blueprint Medicines | — | — | $86 → $115 | Maintains | Overweight | Get Alert | |
| 12/19/2023 | ASND | Buy Now | Ascendis Pharma | $220.00 | -32.27% | $137 → $149 | Maintains | Overweight | Get Alert | |
| 12/19/2023 | ARVN | Buy Now | Arvinas | $12.62 | 399.21% | → $63 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 12/15/2023 | MOR | Buy Now | MorphoSys | — | — | $10 → $17 | Maintains | Overweight | Get Alert | |
| 12/14/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $25.22 | 114.12% | $67 → $54 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 12/13/2023 | SLRN | Buy Now | Acelyrin | — | — | → $11 | Initiates | → Equal-Weight | Get Alert | |
| 11/14/2023 | KZR | Buy Now | Kezar Life Sciences | $6.28 | -68.15% | $4 → $2 | Maintains | Equal-Weight | Get Alert | |
| 11/10/2023 | CABA | Buy Now | Cabaletta Bio | $2.41 | 1310.79% | $39 → $34 | Maintains | Overweight | Get Alert | |
| 11/10/2023 | CLDX | Buy Now | Celldex Therapeutics | $27.88 | -3.16% | → $27 | Upgrade | Underweight → Equal-Weight | Get Alert | |
| 11/08/2023 | RYTM | Buy Now | Rhythm Pharmaceuticals | $113.79 | -64.85% | $38 → $40 | Maintains | Overweight | Get Alert | |
| 09/27/2023 | IMVT | Buy Now | Immunovant | $26.90 | 78.44% | $33 → $48 | Maintains | Overweight | Get Alert | |
| 09/18/2023 | CABA | Buy Now | Cabaletta Bio | $2.41 | 1518.26% | $14 → $39 | Maintains | Overweight | Get Alert | |
| 09/15/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $25.22 | 153.77% | $34 → $64 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 09/06/2023 | ASND | Buy Now | Ascendis Pharma | $220.00 | -39.09% | $139 → $134 | Maintains | Overweight | Get Alert | |
| 08/22/2023 | CLDX | Buy Now | Celldex Therapeutics | $27.88 | -24.68% | → $21 | Initiates | → Underweight | Get Alert | |
| 08/11/2023 | KZR | Buy Now | Kezar Life Sciences | $6.28 | — | — | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 08/10/2023 | ZNTL | Buy Now | Zentalis Pharma | $1.38 | 3523.19% | $51 → $50 | Maintains | Overweight | Get Alert | |
| 07/31/2023 | BPMC | Buy Now | Blueprint Medicines | — | — | — | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 07/28/2023 | ARGX | Buy Now | argenx | $851.52 | -28.48% | $606 → $609 | Maintains | Overweight | Get Alert | |
| 07/24/2023 | IMVT | Buy Now | Immunovant | $26.90 | 22.68% | $27 → $33 | Maintains | Overweight | Get Alert | |
| 07/20/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $25.22 | 110.15% | $76 → $53 | Maintains | Equal-Weight | Get Alert | |
| 06/20/2023 | DICE | Buy Now | DICE Therapeutics | — | — | $38 → $48 | Maintains | Equal-Weight | Get Alert | |
| 06/16/2023 | MOR | Buy Now | MorphoSys | — | — | → $17 | Initiates | → Overweight | Get Alert | |
| 06/14/2023 | BPMC | Buy Now | Blueprint Medicines | — | — | $48 → $55 | Maintains | Equal-Weight | Get Alert | |
| 05/24/2023 | DICE | Buy Now | DICE Therapeutics | — | — | → $38 | Initiates | → Equal-Weight | Get Alert | |
| 05/23/2023 | BPMC | Buy Now | Blueprint Medicines | — | — | $47 → $48 | Maintains | Equal-Weight | Get Alert | |
| 05/12/2023 | KZR | Buy Now | Kezar Life Sciences | $6.28 | 107.01% | $14 → $13 | Maintains | Overweight | Get Alert | |
| 05/05/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $25.22 | 201.35% | $55 → $76 | Maintains | Equal-Weight | Get Alert | |
| 04/25/2023 | MORF | Buy Now | Morphic Holding | — | — | $67 → $80 | Maintains | Overweight | Get Alert | |
| 03/21/2023 | ZYME | Buy Now | Zymeworks | $25.82 | -53.52% | → $12 | Assumes | → Overweight | Get Alert | |
| 03/21/2023 | VTYX | Buy Now | Ventyx Biosciences | $8.13 | 847.11% | → $77 | Initiates | → Overweight | Get Alert | |
| 03/09/2023 | EXEL | Buy Now | Exelixis | $41.62 | -44.74% | → $23 | Initiates | → Overweight | Get Alert | |
| 01/03/2023 | KYMR | Buy Now | Kymera Therapeutics | $89.04 | -52.83% | $40 → $42 | Maintains | Overweight | Get Alert | |
| 01/03/2023 | KZR | Buy Now | Kezar Life Sciences | $6.28 | 122.93% | $17 → $14 | Maintains | Overweight | Get Alert | |
| 01/03/2023 | INCY | Buy Now | Incyte | $97.12 | -22.78% | $72 → $75 | Maintains | Equal-Weight | Get Alert | |
| 01/03/2023 | CABA | Buy Now | Cabaletta Bio | $2.41 | 480.91% | $4 → $14 | Maintains | Overweight | Get Alert | |
| 01/03/2023 | CCCC | Buy Now | C4 Therapeutics | $2.48 | 263.64% | $11 → $9 | Maintains | Equal-Weight | Get Alert | |
| 01/03/2023 | ASND | Buy Now | Ascendis Pharma | $220.00 | -19.55% | $169 → $177 | Maintains | Overweight | Get Alert | |
| 01/03/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $25.22 | 129.98% | → $58 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 01/03/2023 | ARVN | Buy Now | Arvinas | $12.62 | 288.27% | $83 → $49 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 01/03/2023 | GLUE | Buy Now | Monte Rosa Therapeutics | $16.00 | 18.75% | → $19 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 01/03/2023 | BPMC | Buy Now | Blueprint Medicines | — | — | → $41 | Upgrade | Underweight → Equal-Weight | Get Alert | |
| 01/03/2023 | IMVT | Buy Now | Immunovant | $26.90 | 0.37% | $10 → $27 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 12/13/2022 | HZNP | Buy Now | Horizon Therapeutics | — | — | $118 → $116.5 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 11/08/2022 | MORF | Buy Now | Morphic Holding | — | — | $77 → $78 | Maintains | Overweight | Get Alert | |
| 11/08/2022 | KYMR | Buy Now | Kymera Therapeutics | $89.04 | -59.57% | $35 → $36 | Maintains | Overweight | Get Alert | |
| 11/08/2022 | IMVT | Buy Now | Immunovant | $26.90 | -62.83% | $7 → $10 | Maintains | Equal-Weight | Get Alert | |
| 11/08/2022 | CCCC | Buy Now | C4 Therapeutics | $2.48 | 344.44% | $12 → $11 | Maintains | Equal-Weight | Get Alert | |
| 11/07/2022 | ASND | Buy Now | Ascendis Pharma | $220.00 | -23.18% | $172 → $169 | Maintains | Overweight | Get Alert | |
| 10/18/2022 | ARGX | Buy Now | argenx | $851.52 | -44.92% | $461 → $469 | Maintains | Overweight | Get Alert | |
| 10/18/2022 | INCY | Buy Now | Incyte | $97.12 | -22.78% | $76 → $75 | Maintains | Equal-Weight | Get Alert | |
| 09/22/2022 | ASND | Buy Now | Ascendis Pharma | $220.00 | -21.82% | $167 → $172 | Maintains | Overweight | Get Alert | |
| 09/14/2022 | CABA | Buy Now | Cabaletta Bio | $2.41 | 65.98% | $14 → $4 | Maintains | Overweight | Get Alert | |
| 08/29/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | $51 → $71 | Maintains | Overweight | Get Alert | |
| 08/17/2022 | BPMC | Buy Now | Blueprint Medicines | — | — | $40 → $41 | Maintains | Underweight | Get Alert | |
| 08/04/2022 | MORF | Buy Now | Morphic Holding | — | — | $79 → $77 | Maintains | Overweight | Get Alert | |
| 07/28/2022 | INCY | Buy Now | Incyte | $97.12 | -21.75% | → $76 | Initiates | → Equal-Weight | Get Alert | |
| 06/28/2022 | KZR | Buy Now | Kezar Life Sciences | $6.28 | 170.7% | $13 → $17 | Maintains | Overweight | Get Alert | |
| 06/27/2022 | BPMC | Buy Now | Blueprint Medicines | — | — | → $40 | Initiates | → Underweight | Get Alert | |
| 06/01/2022 | KYMR | Buy Now | Kymera Therapeutics | $89.04 | -60.69% | $62 → $35 | Maintains | Overweight | Get Alert | |
| 05/31/2022 | NRIX | Buy Now | Nurix Therapeutics | $19.06 | 31.16% | → $25 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 05/13/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | $53 → $51 | Maintains | Overweight | Get Alert | |
| 05/13/2022 | KZR | Buy Now | Kezar Life Sciences | $6.28 | 107.01% | $14 → $13 | Maintains | Overweight | Get Alert | |
| 05/12/2022 | ASND | Buy Now | Ascendis Pharma | $220.00 | -20% | $190 → $176 | Maintains | Overweight | Get Alert | |
| 05/05/2022 | MORF | Buy Now | Morphic Holding | — | — | $81 → $79 | Maintains | Overweight | Get Alert | |
| 05/04/2022 | KZR | Buy Now | Kezar Life Sciences | $6.28 | 122.93% | $19 → $14 | Maintains | Overweight | Get Alert | |
| 04/11/2022 | NRIX | Buy Now | Nurix Therapeutics | $19.06 | 31.16% | $28 → $25 | Maintains | Equal-Weight | Get Alert | |
| 04/06/2022 | ZNTL | Buy Now | Zentalis Pharma | $1.38 | 4755.07% | → $67 | Initiates | → Overweight | Get Alert | |
| 03/10/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | $42 → $53 | Maintains | Overweight | Get Alert | |
| 03/03/2022 | ASND | Buy Now | Ascendis Pharma | $220.00 | -22.73% | $176 → $170 | Maintains | Overweight | Get Alert | |
| 02/10/2022 | KYMR | Buy Now | Kymera Therapeutics | $89.04 | -30.37% | → $62 | Initiates | → Overweight | Get Alert | |
| 02/10/2022 | NRIX | Buy Now | Nurix Therapeutics | $19.06 | 46.9% | → $28 | Initiates | → Equal-Weight | Get Alert | |
| 02/10/2022 | ARVN | Buy Now | Arvinas | $12.62 | 676.55% | → $98 | Initiates | → Overweight | Get Alert | |
| 02/10/2022 | GLUE | Buy Now | Monte Rosa Therapeutics | $16.00 | 18.75% | → $19 | Initiates | → Equal-Weight | Get Alert | |
| 02/10/2022 | CCCC | Buy Now | C4 Therapeutics | $2.48 | 910.1% | → $25 | Initiates | → Equal-Weight | Get Alert | |
| 12/20/2021 | ARGX | Buy Now | argenx | $851.52 | -53.61% | $390 → $395 | Maintains | Overweight | Get Alert | |
| 12/08/2021 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | → $71 | Initiates | → Overweight | Get Alert | |
| 12/08/2021 | RYTM | Buy Now | Rhythm Pharmaceuticals | $113.79 | -73.64% | → $30 | Initiates | → Overweight | Get Alert | |
| 12/08/2021 | RXDX | Buy Now | Prometheus Biosciences | — | — | → $42 | Initiates | → Overweight | Get Alert | |
| 12/08/2021 | IMVT | Buy Now | Immunovant | $26.90 | -66.54% | → $9 | Initiates | → Equal-Weight | Get Alert | |
| 12/08/2021 | APLS | Buy Now | Apellis Pharmaceuticals | $25.22 | 233.07% | → $84 | Initiates | → Overweight | Get Alert | |
| 12/08/2021 | ARGX | Buy Now | argenx | $851.52 | -54.2% | → $390 | Initiates | → Overweight | Get Alert | |
| 12/08/2021 | ASND | Buy Now | Ascendis Pharma | $220.00 | -20% | → $176 | Initiates | → Overweight | Get Alert | |
| 12/08/2021 | CABA | Buy Now | Cabaletta Bio | $2.41 | 605.39% | → $17 | Initiates | → Overweight | Get Alert | |
| 12/08/2021 | HZNP | Buy Now | Horizon Therapeutics | — | — | → $137 | Initiates | → Overweight | Get Alert | |
| 12/08/2021 | KZR | Buy Now | Kezar Life Sciences | $6.28 | 202.55% | → $19 | Initiates | → Overweight | Get Alert | |
| 12/08/2021 | MORF | Buy Now | Morphic Holding | — | — | → $81 | Initiates | → Overweight | Get Alert | |
| 06/01/2021 | IMVT | Buy Now | Immunovant | $26.90 | -66.54% | $28 → $9 | Downgrade | Buy → Hold | Get Alert | |
| 05/05/2021 | ESPR | Buy Now | Esperion Therapeutics | $3.87 | 416.8% | $37 → $20 | Downgrade | Buy → Hold | Get Alert | |
| 04/06/2021 | RXDX | Buy Now | Prometheus Biosciences | — | — | → $25 | Initiates | → Buy | Get Alert | |
| 03/11/2021 | LUMO | Buy Now | Lumos Pharma | — | — | $4 → $24 | Upgrade | Hold → Buy | Get Alert | |
| 02/02/2021 | IMVT | Buy Now | Immunovant | $26.90 | 22.68% | $54 → $33 | Maintains | Buy | Get Alert | |
| 10/08/2020 | IMVT | Buy Now | Immunovant | $26.90 | 71% | → $46 | Initiates | → Buy | Get Alert | |
| 09/01/2020 | APLS | Buy Now | Apellis Pharmaceuticals | $25.22 | 58.6% | → $40 | Initiates | → Buy | Get Alert | |
| 08/20/2020 | MNTA | Buy Now | Momenta Pharmaceuticals | — | — | $47 → $52.5 | Downgrade | Buy → Hold | Get Alert | |
| 08/20/2020 | PRNB | Buy Now | Principia Biopharma | — | — | $104 → $100 | Downgrade | Buy → Hold | Get Alert | |
| 08/06/2020 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | $60 → $78 | Maintains | Overweight | Get Alert | |
| 08/04/2020 | IVA | Buy Now | Inventiva | $4.36 | 312.84% | → $18 | Initiates | → Buy | Get Alert | |
| 07/23/2020 | GNFT | Buy Now | Genfit | — | — | — | Upgrade | Hold → Buy | Get Alert | |
| 07/10/2020 | GLPG | Buy Now | Galapagos | $31.33 | 516.02% | $298 → $193 | Downgrade | Buy → Hold | Get Alert | |
| 06/09/2020 | VIE | Buy Now | Viela Bio | — | — | → $58 | Initiates | → Hold | Get Alert | |
| 05/12/2020 | CBAY | Buy Now | CymaBay Therapeutics | — | — | $4 → $8 | Upgrade | Hold → Buy | Get Alert | |
| 04/15/2020 | OKE | Buy Now | ONEOK | $73.09 | -43.9% | $61 → $41 | Reiterates | → Buy | Get Alert | |
| 03/31/2020 | AMRN | Buy Now | Amarin Corp | $14.17 | -43.54% | $24 → $8 | Maintains | Hold | Get Alert | |
| 03/19/2020 | NGM | Buy Now | NGM Biopharmaceuticals | — | — | $33 → $32 | Maintains | Buy | Get Alert | |
| 03/17/2020 | DBVT | Buy Now | DBV Technologies | $18.34 | -67.29% | $18 → $6 | Downgrade | Buy → Hold | Get Alert | |
| 03/11/2020 | PRNB | Buy Now | Principia Biopharma | — | — | $66 → $76 | Maintains | Buy | Get Alert | |
| 02/25/2020 | NGM | Buy Now | NGM Biopharmaceuticals | — | — | $26 → $33 | Maintains | Buy | Get Alert | |
| 01/28/2020 | MNTA | Buy Now | Momenta Pharmaceuticals | — | — | $29 → $43 | Maintains | Buy | Get Alert | |
| 01/09/2020 | DBVT | Buy Now | DBV Technologies | $18.34 | -1.88% | $10 → $18 | Upgrade | Hold → Buy | Get Alert | |
| 12/19/2019 | PRNB | Buy Now | Principia Biopharma | — | — | $51 → $66 | Maintains | Buy | Get Alert | |
| 12/16/2019 | AMRN | Buy Now | Amarin Corp | $14.17 | 83.49% | $28 → $26 | Downgrade | Buy → Hold | Get Alert | |
| 11/25/2019 | CBAY | Buy Now | CymaBay Therapeutics | — | — | — | Downgrade | Buy → Hold | Get Alert | |
| 09/18/2019 | ESPR | Buy Now | Esperion Therapeutics | $3.87 | 1708.79% | $112 → $70 | Maintains | Buy | Get Alert | |
| 06/25/2019 | NGM | Buy Now | NGM Biopharmaceuticals | — | — | → $26 | Initiates | → Buy | Get Alert | |
| 06/25/2019 | CBAY | Buy Now | CymaBay Therapeutics | — | — | → $14 | Initiates | → Buy | Get Alert | |
| 04/17/2019 | PRNB | Buy Now | Principia Biopharma | — | — | → $45 | Initiates | → Buy | Get Alert | |
| 03/22/2019 | AMRN | Buy Now | Amarin Corp | $14.17 | 90.54% | → $27 | Initiates | → Buy | Get Alert | |
| 12/11/2018 | VNDA | Buy Now | Vanda Pharma | $6.81 | 325.84% | → $29 | Downgrade | Outperform → Perform | Get Alert | |
| 09/21/2018 | VNDA | Buy Now | Vanda Pharma | $6.81 | 325.84% | $27 → $29 | Maintains | Outperform | Get Alert | |
| 09/14/2018 | DBVT | Buy Now | DBV Technologies | $18.34 | 90.79% | → $35 | Initiates | → Buy | Get Alert | |
| 07/16/2018 | KZR | Buy Now | Kezar Life Sciences | $6.28 | 377.71% | → $30 | Initiates | → Outperform | Get Alert | |
| 06/22/2018 | HRTX | Buy Now | Heron Therapeutics | $1.35 | 3603.7% | $34 → $50 | Maintains | Outperform | Get Alert | |
| 01/03/2018 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | — | Upgrade | Market Perform → Outperform | Get Alert | |
| 11/22/2017 | MNK | Buy Now | Mallinckrodt | — | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 11/15/2017 | URGN | Buy Now | UroGen Pharma | $21.92 | 132.66% | $32 → $51 | Maintains | Outperform | Get Alert | |
| 10/31/2017 | HRTX | Buy Now | Heron Therapeutics | $1.35 | 1900% | → $27 | Initiates | → Outperform | Get Alert | |
| 10/30/2017 | VNDA | Buy Now | Vanda Pharma | $6.81 | 281.79% | $21 → $26 | Maintains | Outperform | Get Alert | |
| 09/07/2017 | PRGO | Buy Now | Perrigo | $13.28 | 562.65% | → $88 | Initiates | → Outperform | Get Alert | |
| 09/07/2017 | PCRX | Buy Now | Pacira BioSciences | $26.34 | — | — | Initiates | → Market Perform | Get Alert | |
| 08/15/2017 | ZYNE | Buy Now | Zynerba Pharmaceuticals | — | — | — | Downgrade | Outperform → Market Perform | Get Alert | |
| 08/03/2017 | TEVA | Buy Now | Teva Pharmaceutical Indus | $29.79 | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 04/12/2017 | VNDA | Buy Now | Vanda Pharma | $6.81 | — | — | Initiates | → Outperform | Get Alert | |
| 09/02/2016 | TEVA | Buy Now | Teva Pharmaceutical Indus | $29.79 | — | — | Upgrade | Perform → Outperform | Get Alert | |
| 02/25/2016 | ESPR | Buy Now | Esperion Therapeutics | $3.87 | 1553.75% | $105 → $64 | Maintains | Buy | Get Alert | |
| 11/12/2015 | ZYNE | Buy Now | Zynerba Pharmaceuticals | — | — | $40 → $34 | Maintains | Outperform | Get Alert | |
| 05/08/2015 | ESPR | Buy Now | Esperion Therapeutics | $3.87 | 2897.42% | $106 → $116 | Maintains | Buy | Get Alert | |
| 05/08/2015 | ESPR | Buy Now | Esperion Therapeutics | $3.87 | 2897.42% | $106 → $116 | Maintains | Buy | Get Alert | |
| 05/08/2015 | CBAY | Buy Now | CymaBay Therapeutics | — | — | $15 → $19 | Maintains | Buy | Get Alert | |
| 03/06/2015 | MNK | Buy Now | Mallinckrodt | — | — | $122 → $140 | Maintains | Outperform | Get Alert | |
| 02/23/2015 | ASND | Buy Now | Ascendis Pharma | $220.00 | — | — | Initiates | → Outperform | Get Alert | |
| 02/17/2015 | ESPR | Buy Now | Esperion Therapeutics | $3.87 | 2225.58% | $60 → $90 | Maintains | Buy | Get Alert | |
| 01/20/2015 | CBAY | Buy Now | CymaBay Therapeutics | — | — | $10 → $15 | Maintains | Buy | Get Alert | |
| 09/17/2014 | CBAY | Buy Now | CymaBay Therapeutics | — | — | → $10 | Initiates | → Buy | Get Alert | |
| 07/16/2014 | MNK | Buy Now | Mallinckrodt | — | — | → $100 | Initiates | → Outperform | Get Alert | |
| 07/22/2013 | ESPR | Buy Now | Esperion Therapeutics | $3.87 | 520.16% | → $24 | Initiates | → Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved